COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,284 Articles (22,759 medRxiv, 8,525 bioRxiv)

Most recent first Previous |  Page 927: Articles 9261-9270  | Next

Experiences of the physicians in the largest COVID-19 dedicated hospital of Bangladesh about COVID-19 and its aftermath
Mahmud, R., Banu, S. S., Sultana, N., Monayem, F. B., Datta, P. K., Hoque, M. M., Habib, S. M. H. R., Abedin, J., Islam, M. F., Arifuzzaman, M., Islam, M. K., Deb, S. R., Chowdhury, A. H., Ahmed, K. G. U., Miah, M. T., Rahman, M. M.
10.1101/2022.02.14.22270965 — Posted: 2022-02-15
A randomized clinical trial of a booster dose with low versus standard dose of AZD1222 in adult after 2 doses of inactivated vaccines
Nanthapisal, S., Puthanakit, T., Jaru-Ampornpan, P., Nantanee, R., Sodsai, P., Himananto, O., Sophonphan, J., Suchartlikitwong, P., Hiransuthikul, N., Angkasekwinai, P., Tangsathapornpong, A., Hirankarn, N.
10.1101/2022.02.15.22270974 — Posted: 2022-02-15
Brain cortical changes are related to inflammatory biomarkers in hospitalized SARS-CoV-2 patients with neurological symptoms
Sanabria Diaz, G., Maja Etter, M., Melie Garcia, L., Lieb, J. M., Psychogios, M.-N., Hutter, G., Granziera, C.
10.1101/2022.02.13.22270662 — Posted: 2022-02-15
Efficacy of Lactococcus lactis strain plasma (LC-Plasma) in easing symptoms in patients with mild coronavirus disease 2019 (COVID-19): protocol for an exploratory, multicenter, double-blinded, randomized controlled trial (PLATEAU study)
Yamamoto, K., Hosogaya, N., Inoue, T., Jounai, K., Tsuji, R., Fujiwara, D., Yanagihara, K., Izumikawa, K., Mukae, H.
10.1101/2022.02.13.22270913 — Posted: 2022-02-15
An observation and restoration model for the COVID-19 incidence curves
Alvarez, L., Morel, J.-D., Morel, J.-M.
10.1101/2022.02.13.22270901 — Posted: 2022-02-15
Required COVID-19 Vaccination Certification to Attend Certain U.S. Professional Football Games in Fall 2021: A Natural Experiment
Robertson, L. S.
10.1101/2022.02.13.22270900 — Posted: 2022-02-15
An extended SIR model with vaccine dynamics for SARS-CoV-2 adaptation rate
Suric, T., Horvat, R.
10.1101/2022.02.11.22270784 — Posted: 2022-02-15
Assessing the Profile of Unvaccinated COVID-19 Individuals in African American and Latinx Communities in Eastern Pennsylvania
Colvin, K. M., Camera, K. S., Adams, L. S., Sarpong, A. P., Fuller, D. G., Peck, S. E., Ramos, A. S., Acevedo, A. L., Badume, M. A., Briggs, S.-l. A., Chukwurah, T. N., Davila-Gutierrez, Z., Ewing, J. A., Frempong, J. O., Garrett, A. A., Grampp, S. J., Gillespie, J. W., Herrera, E. J., Maddox, E. J., Pelaez, J. C., Quartey, O. L., Rodriguez, F., Vasquez, L. A., Piper, B. J., Gowtham, S.
10.1101/2022.02.11.22270504 — Posted: 2022-02-15
Clinical and economic benefits of lenzilumab plus standard of care compared with standard of care alone for the treatment of hospitalized patients with Coronavirus Disease 19 (COVID-19) from the perspective of National Health Service England
Kilcoyne, A., Jordan, E., Thomas, K., Pepper, A. N., Zhou, A., Chappell, D., Amarapala, M., Theriault, R.-K., Thompson, M.
10.1101/2022.02.11.22270859 — Posted: 2022-02-15
COVID-19 mortality and excess mortality among working-age Californians, by occupational sector: March 2020 through November 2021
Chen, Y.-H., Riley, A. R., Duchowny, K. A., Aschmann, H. E., Chen, R., Kiang, M. V., Mooney, A., Stokes, A. C., Glymour, M. M., Bibbins-Domingo, K.
10.1101/2022.02.14.22270958 — Posted: 2022-02-15

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).